Skip to content

Physical Exercise During the Cancer Care Pathway

Physical Exercise During the Cancer Care Pathway

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07652502
Acronym
ECOLE
Enrollment
370
Registered
2026-06-17
Start date
2026-06-15
Completion date
2027-10-30
Last updated
2026-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Cancer, Treatment-Related, Oncologic Disorders, Oncology

Brief summary

Background: Physical exercise is proven safe and effective in improving quality of life and reducing treatment-related side effects in oncology. However, patient adherence to international guidelines remains suboptimal. Investigating the knowledge, attitudes, and practices (KAP) regarding physical activity is crucial to identifying unmet educational needs and barriers. Objective: This multicenter, cross-sectional observational study (ECOLE project) aims to assess KAP levels concerning exercise among cancer patients and explore the correlations between KAP scores and sociodemographic or clinical variables. Methods: Over a 6-month period, an anonymous online survey (Microsoft Forms) will be administered to adult cancer patients (≥18 years old) at any disease or treatment stage. A minimum sample size of 370 participants is targeted. Statistical analyses will include Descriptive Statistics, Exploratory and Confirmatory Factor Analyses to validate KAP scales, and Multivariable Logistic Regression to identify predictors of adherence (≥150 minutes/week) and perceived barriers or facilitators. Expected Results: The study will provide a comprehensive overview of physical activity perceptions and behaviors in oncology. These insights will support the design of targeted educational interventions and structured exercise programs, contributing to the development of a novel "Exercise Oncology Specialist" within supportive care teams.

Interventions

None listed

Sponsors

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years * Oncological diagnosis * Ability to understand the language of the respective country of origin * Electronic informed consent

Exclusion criteria

\- Failure to accept the informed consent

Design outcomes

Primary

MeasureTime frameDescription
physical exercise in cancer patients.1 dayTo evaluate the level of knowledge, attitudes, and practices (KAP) related to physical by administering the study survey exercise in cancer patients.

Secondary

MeasureTime frameDescription
safety of physical exercise oncology1 dayDetermine the level of knowledge regarding the benefits and safety of physical exercise by administering the study survey.
self-efficacy regarding exercise oncology1 dayEvaluate attitudes, perceptions, and self-efficacy regarding physical activity by administering the study survey.
relationship between exercise oncology and oncological journey1 dayAnalyze the potential relationship between knowledge, attitudes, and the practice of physical exercise
demographic and clinical variables in exercise oncology1 dayExplore the role of demographic and clinical variables (e.g., age, sex, tumor type, phase of treatment) by administering the study questionnaire.
barriers and facilitators to exercise oncology1 dayIdentify potential barriers and facilitators to the practice of physical exercise by administering the study questionnaire.
interest of cancer patients in exercise oncology1 dayAssess the interest of cancer patients in structured physical exercise programs by administering the study questionnaire.

Countries

France, Romania

Contacts

CONTACTStefano Magno
stefano.magno@policlinicogemelli.it+390630157077
PRINCIPAL_INVESTIGATORStefano Magno

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 27, 2026